The OIG has indicated concern that patients suffering from opioid use disorder may experience difficulty accessing medication-assisted treatment (MAT), resulting in under-utilization of this intervention that offers what the...more
7/25/2020
/ Audits ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Medicare ,
Medicare Part D ,
Medication-Assisted Treatment (MAT) ,
OIG ,
Opioid ,
SAMHSA ,
Substance Abuse ,
Waivers ,
Work Plans
Congress significantly eased restrictions on disclosing information that identifies substance use disorder (SUD) patients, while simultaneously strengthening protection for SUD patients from discrimination and liability based...more
A waiver granted by the Drug Enforcement Administration (DEA) may provide a solution for long term care providers with opioid-addicted residents who are unable to access medication-assisted treatment (MAT) due to...more
As federal agencies scramble to provide regulatory relief from the fall-out of the coronavirus pandemic taking hold in the United States, several waivers and bulletins provide guidance specifically applicable to substance use...more